Published: 2021-12-23

Effect of amitriptyline and pregabalin on heart rate variability and electrolytes in neurotrophic pain in diabetic patients

Rohan Srivastava, N. D. Kantharia


Background: The data regarding effects of amitriptyline and pregabalin on heart rate variability in patients with neuropathic pain in diabetic patients are poorly understood in India. The present study was conducted to evaluate the effect of amitriptyline and pregabalin on heart rate variability in diabetic patients with neuropathic pain and their effect on serum electrolyte (sodium and potassium).

Methods: The patients include 60 diabetic patients of either sex aged 18-65 years diagnosed with neuropathic pain and divided into two groups. The study was prospective open label and observational study. Group 1 was treated with amitriptyline 10 mg once a day while group 2 with pregabalin 75 mg once a day and HRV, serum sodium and serum potassium levels and pain score were recorded; and data of post-treatment at 2 and 4 weeks were compared with pretreatment values (control). All the statistical analysis was performed by using SPSS 20.0 software.

Results: Both the drugs have increased HRV and reduced neuropathic pain intensity after 2 and 4 weeks treatment. The sodium and potassium level were not altered by these drugs. No correlation was observed between HRV and neuropathic pain.

Conclusions: In conclusion, both the amitriptyline and pregabalin have significantly increased HRV and reduced the neuropathic pain intensity; but no correlation was observed between increased HRV and reduced neuropathic pain intensity.


Heart rate variability, Amitriptyline, Pregabalin, Neuropathic pain, Electrolytes

Full Text:



Garland EL. Pain processing in the human nervous system. a selective review of nociceptive and biobehavioral pathways. Clin Office Pract. 2012; 39(3):561-71.

Bennett MI. Theories, history and current taxonomy. In: Neuropathic pain. Newzeland: Elsevier;2010.

Karri J, Zhang L, Li S, Chen Y-T, Stampas A, Li S. Heart Rate Variability: A Novel modality for diagnosing neuropathic pain after spinal cord injury. Front Physiol. 2017; 8:495.

Van Ravenswaaij-Arts C, Kollée L, Hopman J, Stoelinga G, Van Geijn H. Heart rate variability. Ann Intern Med. 1993;15;118(6):436-47.

Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol. 1994;14(6):392-5.

Vinik A, Maser R, Mitchell B, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5): 1553-79.

Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: Current evidence and future directions. Curr Opinion Anaesthesiol. 2007;20(5):456-72.

Ermis N, Gullu H, Caliskan M, Unsal A, Kulaksizoglu M, Muderrisoglu H. Gabapentin therapy improves heart rate variability in diabetic patients with peripheral neuropathy. J Diab Complicat. 2010;24(4):229-33.

Jiang W, Ladd S, Martsberger C, Feinglos M, Spratt SE, Kuchibhatla M, et al. Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. J Clin Psychopharmacol. 2011;31(2): 207-13.

Chakrabarty S, Das A, Ganguly A. A prospective, randomised, comparative study of efficacy and safety of pregabalin, duloxetine and amitriptyline in patients of painful diabetic neuropathy in a tertiary care teaching hospital in rural Bengal. J Evolution Med Dent Sci. 2016;5(35):2025-9.

Kaur H, Hota D, Bhansali A, Dutta P, Bansal D, Chakrabarti A. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: A randomized, double-blind, cross-over clinical trial. Diab Care. 2011;34(4):818-22.

Baidya DK, Agarwal A, Khanna P, Arora MK. Pregabalin in acute and chronic pain. J Anaesthesiol Clin Pharmacol. 2011;27:307-14.

Fink K, Meder W, Dooley DJ, Göthert M. Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol. 2000; 130(4):900-6.

Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 2003; 105(2):131-41.

Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opinion Pharmacol. 2006; (1): 108-13.

Kweon TD, Kim JY, Kwon IW, Choi JB, Lee YW. Participation of K(ATP) Channels in the Antinociceptive Effect of Pregabalin in Rat Formalin Test. Korean J Pain. 2011;24:131–6.

Devi P, Madhu K, Ganapathy B, Sarma G, John L, Kulkarni C. Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy. Indian J Pharmacol. 2012;44:51-6.

Chang M, Tsay J. Relationships between pain intensity and heart rate variability in patients after abdominal surgery: a Pilot Study. Chinese Med J. 2012;125(11):196.